Eli Lilly GLP-1 Drug Revenue Growth Infographic Template

About this finance infographic

This Eli Lilly GLP-1 Drug Revenue Growth Infographic turns Eli Lilly Investor Relations's reported figures into a clear finance visual for earnings, market report, and business model learning. It uses a revenue mix chart layout to connect Total revenue, Mounjaro revenue, and Zepbound revenue with source-aware explanation. Built as a Financial Report Infographic Generator example, it helps readers scan the source, understand the metric relationships, and compare the business context without copying long source text or offering investment advice.

Template details

Topic

Eli Lilly GLP-1 Drug Revenue Growth

Aspect ratio

9:16

Structure

revenue mix chart

Style

Financial Editorial Report Style

Category

Financial Report

Download

Disabled

Key learning points

• Total revenue is the anchor figure for this revenue mix chart view: $45.0 billion in 2024.
• Mounjaro revenue adds a different lens, helping the poster avoid reducing the topic to one headline metric.
• Zepbound revenue provides the third data layer so the visual can separate scale, mix, margin, or operating pressure.
• The core interpretation is to show GLP-1 product revenue within the pharmaceutical portfolio.
• The risk context is specific: medical efficacy claims should not be added.

Source and data points

Eli Lilly Investor Relations reports eli lilly glp-1 drug revenue growth through company-disclosed metrics. The infographic uses the source as a data anchor and turns the figures into original, non-advisory financial explanation.

Total revenue

$45.0 billion

2024

Mounjaro revenue

$11.5 billion

2024

Zepbound revenue

$4.9 billion

2024